中/EN
中文繁體
English
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company Presentations
Stock Quotes & Charts
Analyst Coverage
FAQs
IR Contact
Corporate
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company
Presentations
Stock Quotes &
Charts
Analyst Coverage
FAQs
IR Contact
Press Releases
2011
Please select
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
SEP
01
The United Laboratories International Holdings Limited Announces 2011 Interim Results, Turnover Increased 9.6% to Approximately HK$3.37 Billion
MAR
22
Remarkable Results for Supportive Long-term Stakeholders, Product Innovation for Continuous Long-term Growth
JAN
04
TUL Obtained Approval for All Recombinant Human Insulin Products - A New Era Begins
